BE837848A - Thiourees et thiocarbamates, procede pour les preparer et compositions pharmaceutiques les contenant - Google Patents

Thiourees et thiocarbamates, procede pour les preparer et compositions pharmaceutiques les contenant

Info

Publication number
BE837848A
BE837848A BE163748A BE163748A BE837848A BE 837848 A BE837848 A BE 837848A BE 163748 A BE163748 A BE 163748A BE 163748 A BE163748 A BE 163748A BE 837848 A BE837848 A BE 837848A
Authority
BE
Belgium
Prior art keywords
thiourees
thiocarbamates
preparing
pharmaceutical compositions
compositions containing
Prior art date
Application number
BE163748A
Other languages
English (en)
Inventor
T H Brown
G J Durant
C R Ganellin
R J Ife
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE837848A publication Critical patent/BE837848A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BE163748A 1975-02-03 1976-01-23 Thiourees et thiocarbamates, procede pour les preparer et compositions pharmaceutiques les contenant BE837848A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4538/75A GB1542840A (en) 1975-02-03 1975-02-03 Heterocyclic dithiocarbamates and isothioureas

Publications (1)

Publication Number Publication Date
BE837848A true BE837848A (fr) 1976-07-23

Family

ID=9779069

Family Applications (1)

Application Number Title Priority Date Filing Date
BE163748A BE837848A (fr) 1975-02-03 1976-01-23 Thiourees et thiocarbamates, procede pour les preparer et compositions pharmaceutiques les contenant

Country Status (11)

Country Link
US (1) US4056621A (fr)
JP (3) JPS6044302B2 (fr)
AU (1) AU502509B2 (fr)
BE (1) BE837848A (fr)
CA (1) CA1067501A (fr)
DE (1) DE2604056A1 (fr)
FR (1) FR2299026A1 (fr)
GB (1) GB1542840A (fr)
IE (1) IE42470B1 (fr)
NL (1) NL7600906A (fr)
ZA (1) ZA7682B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4239908A (en) * 1979-12-10 1980-12-16 G.D. Searle & Co. N-aralkenyl-N'-cyano-N"-(heterocyclylthioalkyl)-guanidines
JPS57130975A (en) * 1981-02-06 1982-08-13 Fujimoto Seiyaku Kk Preparation of imidazole derivative
JPS57212165A (en) * 1981-06-25 1982-12-27 Fujimoto Seiyaku Kk Imidazole derivative and its preparation
JPS57212166A (en) * 1981-06-25 1982-12-27 Fujimoto Seiyaku Kk Imidazole derivative and its preparation
JPS57212170A (en) * 1981-06-25 1982-12-27 Fujimoto Seiyaku Kk Production of guanidine derivative
US5380747A (en) * 1992-10-30 1995-01-10 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5807884A (en) * 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5783596A (en) * 1992-10-30 1998-07-21 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5792787A (en) * 1995-06-07 1998-08-11 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5922761A (en) * 1996-09-06 1999-07-13 Medinox, Inc. Methods for in vivo reduction of iron levels and compositions useful therefor
WO2022034121A1 (fr) 2020-08-11 2022-02-17 Université De Strasbourg Bloqueurs de h2 ciblant des macrophages du foie pour la prévention et le traitement d'une maladie du foie et du cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458528A (en) * 1965-07-07 1969-07-29 Merck & Co Inc Nitroimidazole carbonates and thionocarbonates
US3773781A (en) * 1966-07-18 1973-11-20 Merck & Co Inc 1-substituted-5-nitroimidazol-2-ylalkyl-(n-substituted)-carbamates
US3790593A (en) * 1966-07-18 1974-02-05 J Carlson 1-substituted-5-nitroimidazol-2-ylalkyl-(n-substituted)-carbamates
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3759944A (en) * 1970-10-14 1973-09-18 Smith Kline French Lab Isothioureas and their derivatives
CA967961A (en) * 1972-09-28 1975-05-20 Robert C. Tweit 2-(2-(2-methyl-5-nitro-1-imidazolyl)ethyl1-2-thiopseudoureas and related compounds
GB1431589A (en) * 1973-07-13 1976-04-07 Smith Kline French Lab Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups

Also Published As

Publication number Publication date
GB1542840A (en) 1979-03-28
NL7600906A (nl) 1976-08-05
FR2299026A1 (fr) 1976-08-27
FR2299026B1 (fr) 1979-09-21
JPS58150568A (ja) 1983-09-07
AU502509B2 (en) 1979-07-26
JPS51101976A (fr) 1976-09-08
CA1067501A (fr) 1979-12-04
AU1039476A (en) 1977-07-28
JPS6044302B2 (ja) 1985-10-02
JPS6343390B2 (fr) 1988-08-30
DE2604056A1 (de) 1976-08-05
ZA7682B (en) 1976-12-29
JPS6343391B2 (fr) 1988-08-30
JPS58150569A (ja) 1983-09-07
US4056621A (en) 1977-11-01
IE42470B1 (en) 1980-08-13
IE42470L (en) 1976-08-03

Similar Documents

Publication Publication Date Title
FR2338271A1 (fr) Derives du phtalane, procede pour leur preparation, et compositions pharmaceutiques contenant de tels derives
BE784136A (fr) Nouvelles compositions pharmaceutiques et procede pour les preparer
MC1390A1 (fr) Derives de pyrazolopyridazine,procede pour leur preparation et compositions pharmaceutiques les contenant
BE849810A (fr) Nouvelles pyrimidones, procede pour les preparation et compositions pharmaceutiques les contenant
LU81132A1 (fr) 2-(2-thenoylthio)-propionylglycine,procede pour sa preparation et compositions pharmaceutiques la contenant
FR2313918A1 (fr) Methoxy-2 benzenesulfonamides n-substitues, procede pour les preparer et medicaments les contenant
BE842252A (fr) Procede radioisotopique pour le marquage de produits pharmaceutiques lyophileses
BE837848A (fr) Thiourees et thiocarbamates, procede pour les preparer et compositions pharmaceutiques les contenant
BE885385A (fr) Derives de d-6-n-propylergolines, leur procede de preparation et compositions pharmaceutiques en contenant
FR2346324A1 (fr) Nouvelles amidino-urees, procede pour leur preparation et medicaments les renfermant
FR2326202A2 (fr) L-norleucine-13 motiline. procede pour sa preparation et composition la contenant
BE829327A (fr) Nouvelles pyridorenzepimunes, procedes pour les preparer et medicaments les contenant
BE809179A (fr) Nouvelles cyclopropylamines, leur procede d'obtention et les compositions pharmaceutiques en contenant
BE848909A (fr) Nouvelles isothiourees, procede pour les preparer et compositions pharmaceutiques les contenant
PT66489B (fr) Procede pour la preparation des produits pharmaceutique contenant polihydroxiphenil cromanones
BE803474A (fr) Nouvelles 2-alkylamino-dihydropyridines, leur procede de preparation et compositions pharmaceutiques les contenant
FR2304343A1 (fr) Nouvelles cephalosporines, procede pour leur obtention et compositions pharmaceutiques les contenant
FR2322591A1 (fr) Arylalkylamides, presentant une activite antidepressive, procede pour leur obtention et compositions pharmaceutiques les contenant
BE835744A (fr) Derives de 5,7-dihydroxytetraisoquinoline, procede pour leur preparation et compositions pharmaceutiques contenant de tels derives
BE875091A (fr) Derives de substitution de spirooxazolidinone steroidienne, leur procede de preparation et compositions pharmaceutiques les contenant
FR2274291A1 (fr) Nouvelles compositions pharmaceutiques et procede pour leur preparation
PT65151A (fr) Procede pour la preparation de nouvelles solutions pharmaceutiques stables
FR2291751A1 (fr) Derives de phenyl-pyridylamine, procede pour leur obtention et application pharmaceutique
FR2315910A1 (fr) Compositions pharmaceutiques contenant de la " debrycine " heterocolloidale et procede pour leur preparation
BE843412A (fr) Tetrahydroisoquinoleines substituees, procede pour les preparer et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SMITH KLINE & FRENCH LABORATORIES LTD

Effective date: 19840123